An Update on Animal Models of Osteogenesis Imperfecta

被引:2
|
作者
Lv, Fang [1 ]
Cai, Xiaoling [1 ]
Ji, Linong [1 ]
机构
[1] Peking Univ Peoples Hosp, Dept Endocrinol & Metab, Xizhimen South St 11, Beijing 100044, Peoples R China
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
Osteogenesis imperfecta; Mouse models; Zebrafish models; Mechanism; SCLEROSTIN ANTIBODY TREATMENT; TRANSGENIC MOUSE MODEL; MARROW STROMAL CELLS; OIM MICE EXHIBIT; BONE FRAGILITY; PROLYL; 3-HYDROXYLATION; RETROVIRUS INSERTION; MURINE MODEL; COLLAGEN; MUTATIONS;
D O I
10.1007/s00223-022-00998-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteogenesis imperfecta (OI) is a heterogeneous disorder characterized by bone fragility, multiple fractures, bone deformity, and short stature. In recent years, the application of next generation sequencing has triggered the discovery of many new genetic causes for OI. Until now, more than 25 genetic causes of OI and closely related disorders have been identified. However, the mechanisms of many genes on skeletal fragility in OI are not entirely clear. Animal models of OI could help to understand the cellular, signaling, and metabolic mechanisms contributing to the disease, and how targeting these pathways can provide therapeutic targets. To date, a lot of animal models, mainly mice and zebrafish, have been described with defects in 19 OI-associated genes. In this review, we summarize the known genetic causes and animal models that recapitulate OI with a main focus on engineered mouse and zebrafish models. Additionally, we briefly discuss domestic animals with naturally occurring OI phenotypes. Knowledge of the specific molecular basis of OI will advance clinical diagnosis and potentially stimulate targeted therapeutic approaches.
引用
收藏
页码:345 / 366
页数:22
相关论文
共 50 条
  • [31] Osteogenesis Imperfecta: Current and Prospective Therapies
    Botor, Malwina
    Fus-Kujawa, Agnieszka
    Uroczynska, Marta
    Stepien, Karolina L.
    Galicka, Anna
    Gawron, Katarzyna
    Sieron, Aleksander L.
    BIOMOLECULES, 2021, 11 (10)
  • [32] Advances in the Classification and Treatment of Osteogenesis Imperfecta
    Thomas, Inas H.
    DiMeglio, Linda A.
    CURRENT OSTEOPOROSIS REPORTS, 2016, 14 (01) : 1 - 9
  • [33] Dissecting the phenotypic variability of osteogenesis imperfecta
    Garibaldi, Nadia
    Besio, Roberta
    Dalgleish, Raymond
    Villani, Simona
    Barnes, Aileen M.
    Marini, Joan C.
    Forlino, Antonella
    DISEASE MODELS & MECHANISMS, 2022, 15 (05)
  • [34] Osteogenesis imperfecta: a review
    Ablin, DS
    CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES, 1998, 49 (02): : 110 - 123
  • [35] Modern classification and molecular-genetic aspects of osteogenesis imperfecta
    Zaripova, A. R.
    Khusainova, R., I
    VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII, 2020, 24 (02): : 219 - 227
  • [36] Osteogenesis imperfecta: Recent findings shed new light on this once well-understood condition
    Basel, Donald
    Steiner, Robert D.
    GENETICS IN MEDICINE, 2009, 11 (06) : 375 - 385
  • [37] Muscle transcriptome in mouse models of osteogenesis imperfecta
    Moffatt, Pierre
    Boraschi-Diaz, Iris
    Bardai, Ghalib
    Rauch, Frank
    BONE, 2021, 148
  • [38] Osteogenesis imperfecta in the dachshund
    Schutz, Ekkehard
    Droegemueller, Cord
    Leeb, Tosso
    Scharfenstein, Melanie
    Brenig, Bertram
    KLEINTIERPRAXIS, 2012, 57 (02): : 57 - +
  • [39] Clinical Application of Antenatal Genetic Diagnosis of Osteogenesis Imperfecta Type IV
    Yuan, Jing
    Li, Song
    Xu, YeYe
    Cong, Lin
    MEDICAL SCIENCE MONITOR, 2015, 21 : 964 - 969
  • [40] Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment
    Trejo, P.
    Rauch, F.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (12) : 3427 - 3437